Company page
Chimeric Therapeutics Limited
Chimeric Therapeutics Limited, trading under the ticker CHM, is a public company listed on the Australian market. The company has a market capitalization of approximately AUD 2.68 million. Chimeric Therapeutics focuses on developing innovative therapies in the field of cell and gene therapy.
- Ticker
- CHM:ASX
- Asset type
- Stock
- Market cap
- $2.7M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- ASX
- Currency
- AUD